Nuveen Asset Management, LLC Akero Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 144,863 shares of AKRO stock, worth $3.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

144,863

Previous 132,141 9.63%

Holding current value

$3.32 Million

Previous $3.09 Million 18.61%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.76 - $31.18 $225,942 - $396,671	12,722 Added 9.63%	144,863 $3.66 Million
Q4 2023 Feb 14, 2024	BUY	$11.38 - $50.33 $7,488 - $33,117	658 Added 0.5%	132,141 $3.09 Million
Q3 2023 Nov 14, 2023	BUY	$41.19 - $52.25 $312,673 - $396,629	7,591 Added 6.13%	131,483 $6.65 Million
Q2 2023 Aug 14, 2023	BUY	$36.89 - $56.88 $1.16 Million - $1.79 Million	31,513 Added 34.11%	123,892 $5.78 Million
Q1 2023 May 15, 2023	SELL	$37.27 - $50.24 $303,340 - $408,903	-8,139 Reduced 8.1%	92,379 $3.53 Million

Q4 2022 Feb 14, 2023	SELL	$33.44 - $54.8 $1.06 Million - $1.74 Million	-31,727 Reduced 23.99%	100,518 $1.23 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $353,220 - $1.18 Million	34,800 Added 35.71%	132,245 $1.62 Million
Q2 2022 Aug 15, 2022	BUY	$8.0 - $15.01 $111,040 - $208,338	13,880 Added 16.61%	97,445 $921,000
Q1 2022 May 16, 2022	BUY	$12.97 - $22.26 $12,139 - $20,835	936 Added 1.13%	83,565 $1.2 Million
Q4 2021 Feb 14, 2022	SELL	$19.87 - $26.24 $125,399 - $165,600	-6,311 Reduced 7.1%	82,629 $1.62 Million
Q3 2021 Nov 12, 2021	SELL	$18.65 - $25.46 $100,411 - $137,076	-5,384 Reduced 5.71%	88,940 $2.21 Million
Q2 2021 Aug 16, 2021	BUY	$24.81 - $32.35 $1.09 Million - $1.42 Million	43,958 Added 87.28%	94,324 $2.34 Million
Q1 2021 May 17, 2021	SELL	$24.04 - $34.19 $22,573 - $32,104	-939 Reduced 1.83%	50,366 $1.46 Million
Q4 2020 Feb 16, 2021	SELL	$25.12 - $29.89 $440,077 - $523,642	-17,519 Reduced 25.45%	51,305 $1.32 Million
Q3 2020 Nov 16, 2020	BUY	$30.79 - $39.92 $743,055 - $963,389	24,133 Added 54.0%	68,824 $2.12 Million
Q2 2020 Aug 14, 2020	BUY	$19.25 - $26.76 $518,113 - $720,245	26,915 Added 151.41%	44,691 $1.11 Million
Q1 2020 May 14, 2020	BUY	$12.8 - $27.05 $227,532 - $480,840	17,776 New	17,776 $376,000

Others Institutions Holding AKRO

# of Institutions

193

Shares Held

74.2M

Call Options Held

429K

Put Options Held

591K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.06B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Akero Therapeutics, Inc. Transaction History